Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 25 of 40  Show
  1. 1
    "Identification and tissue distribution of the novel human cytochrome P450 2S1 (CYP2S1)."
    Rylander T., Neve E., Ingelman-Sundberg M., Oscarson M.
    Biochem. Biophys. Res. Commun. 281:529-535(2001) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, TISSUE SPECIFICITY.
    Category: Subcellular Location, Expression, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  2. 2
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1015 other entries.

  3. 3
    "Complete sequencing and characterization of 21,243 full-length human cDNAs."
    Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.
    , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.
    Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 12930 other entries.

  4. 4
    "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
    The MGC Project Team
    Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
    Category: Sequences.
    Tissue: Blood.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 50481 other entries.

  5. 5
    "Specific dehydrogenation of 3-methylindole and epoxidation of naphthalene by recombinant human CYP2F1 expressed in lymphoblastoid cells."
    Lanza D.L., Code E., Crespi C.L., Gonzalez F.J., Yost G.S.
    Drug Metab. Dispos. 27:798-803(1999) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: PathwayImported.
    Source: Reactome:R-HSA-2980785.

    This publication is mapped to 9 other entries.

  6. 6
    "Cytochrome P450 2E1 is the primary enzyme responsible for low-dose carbon tetrachloride metabolism in human liver microsomes."
    Zangar R.C., Benson J.M., Burnett V.L., Springer D.L.
    Chem. Biol. Interact. 125:233-243(2000) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: PathwayImported.
    Source: Reactome:R-HSA-2980785.

    This publication is mapped to 10 other entries.

  7. 7
    "Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation."
    Manyike P.T., Kharasch E.D., Kalhorn T.F., Slattery J.T.
    Clin. Pharmacol. Ther. 67:275-282(2000) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: PathwayImported.
    Source: Reactome:R-HSA-2980785.

    This publication is mapped to 10 other entries.

  8. 8
    "Cytochrome P450 isozymes involved in the metabolism of phenol, a benzene metabolite."
    Powley M.W., Carlson G.P.
    Toxicol. Lett. 125:117-123(2001) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: PathwayImported.
    Source: Reactome:R-HSA-2980785.

    This publication is mapped to 10 other entries.

  9. 9
    "Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation."
    Xie H.J., Yasar U., Lundgren S., Griskevicius L., Terelius Y., Hassan M., Rane A.
    Pharmacogenomics J. 3:53-61(2003) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: PathwayImported.
    Source: Reactome:R-HSA-2980785.

    This publication is mapped to 13 other entries.

  10. 10
    "Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases."
    Smith G., Wolf C.R., Deeni Y.Y., Dawe R.S., Evans A.T., Comrie M.M., Ferguson J., Ibbotson S.H.
    Lancet 361:1336-1343(2003) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: PathwayImported.
    Source: Reactome:R-HSA-2980785.
  11. 11
    "Identification of genetic polymorphisms of CYP2S1 in a Finnish Caucasian population."
    Saarikoski S.T., Suitiala T., Holmila R., Impivaara O., Jarvisalo J., Hirvonen A., Husgafvel-Pursiainen K.
    Mutat. Res. 554:267-277(2004) [PubMed] [Europe PMC] [Abstract]
    Annotation: Observational study of genotype prevalence. (HuGE Navigator)Imported.
    Source: GeneRIF:29785.

    This publication is mapped to 1 other entry.

  12. 12
    "P450 2C18 catalyzes the metabolic bioactivation of phenytoin."
    Kinobe R.T., Parkinson O.T., Mitchell D.J., Gillam E.M.
    Chem. Res. Toxicol. 18:1868-1875(2005) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: PathwayImported.
    Source: Reactome:R-HSA-2980785.

    This publication is mapped to 4 other entries.

  13. 13
    "Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects."
    Guengerich F.P., Kim D.H., Iwasaki M.
    Chem. Res. Toxicol. 4:168-179(1991) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: PathwayImported.
    Source: Reactome:R-HSA-2980785.

    This publication is mapped to 10 other entries.

  14. 14
    "A novel promoter element containing multiple overlapping xenobiotic and hypoxia response elements mediates induction of cytochrome P4502S1 by both dioxin and hypoxia."
    Rivera S.P., Wang F., Saarikoski S.T., Taylor R.T., Chapman B., Zhang R., Hankinson O.
    J. Biol. Chem. 282:10881-10893(2007) [PubMed] [Europe PMC] [Abstract]
    Annotation: identify a novel regulatory cassette that mediates changes in Cyp2s1 expressionImported.
    Source: GeneRIF:29785.

    This publication is mapped to 3 other entries.

  15. 15
    "Expression of CYP2S1 in human hepatic stellate cells."
    Marek C.J., Tucker S.J., Koruth M., Wallace K., Wright M.C.
    FEBS Lett. 581:781-786(2007) [PubMed] [Europe PMC] [Abstract]
    Annotation: The presence of a CYP2A-related protein and testosterone metabolism in stellate cell cultures suggest that stellate cells express specific functional isoforms of CYP of which a major form is CYP2S1Imported.
    Source: GeneRIF:29785.

    This publication is mapped to 1 other entry.

  16. 16
    "Three novel single nucleotide polymorphisms (SNPs) of CYP2S1 gene in Japanese individuals."
    Hanzawa Y., Sasaki T., Hiratsuka M., Ishikawa M., Mizugaki M.
    Drug Metab. Pharmacokinet. 22:136-140(2007) [PubMed] [Europe PMC] [Abstract]
    Annotation: Observational study of genotype prevalence. (HuGE Navigator); identified the following three novel single nucleotide polymorphisms (SNPs): 4612G>A (Glu147Glu) in exon 3 5478C>T (Leu230Leu) and 5479T>G (Leu230Arg CYP2S1*5A) in exon 5 in Japanese individualsImported.
    Source: GeneRIF:29785.

    This publication is mapped to 1 other entry.

  17. 17
    "CYP2S1 gene polymorphisms in a Korean population."
    Jang Y.J., Cha E.Y., Kim W.Y., Park S.W., Shon J.H., Lee S.S., Shin J.G.
    Ther Drug Monit 29:292-298(2007) [PubMed] [Europe PMC] [Abstract]
    Annotation: 12 genetic variations which included the two novel nonsynonymous mutations CYP2S1 S61N (0.3%) and CYP2S1 L230R (0.8%) were identified in 50 Korean subjectsImported.
    Source: GeneRIF:29785.

    This publication is mapped to 1 other entry.

  18. 18
    "Association study between single-nucleotide polymorphisms in 199 drug-related genes and commonly measured quantitative traits of 752 healthy Japanese subjects."
    Saito A., Kawamoto M., Kamatani N.
    J. Hum. Genet. 54:317-323(2009) [PubMed] [Europe PMC] [Abstract]
    Annotation: Observational study of gene-disease association. (HuGE Navigator)Imported.
    Source: GeneRIF:29785.

    This publication is mapped to 949 other entries.

  19. 19
    "Characterization and expression of extrahepatic CYP2S1."
    Deb S., Bandiera S.M.
    Expert Opin Drug Metab Toxicol 5:367-380(2009) [PubMed] [Europe PMC] [Abstract]
    Annotation: Review compares the expression of CYP2S1 mRNA and protein in humans mice and rats and critically examines evidence pertaining to CYP2S1 regulation and its catalytic activity.Imported.
    Source: GeneRIF:29785.

    This publication is mapped to 1 other entry.

  20. 20
    "Functional characterization of human cytochrome P450 2S1 using a synthetic gene-expressed protein in Escherichia coli."
    Bui P.H., Hankinson O.
    Mol. Pharmacol. 76:1031-1043(2009) [PubMed] [Europe PMC] [Abstract]
    Annotation: CYP2S1 contributes to the metabolism of environmental carcinogens via a nicotinamide adenine dinucleotide phosphate (NADPH)- independent activity.Imported.
    Source: GeneRIF:29785.

    This publication is mapped to 1 other entry.

  21. 21
    "Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9."
    Veronese M.E., Mackenzie P.I., Doecke C.J., McManus M.E., Miners J.O., Birkett D.J.
    Biochem. Biophys. Res. Commun. 175:1112-1118(1991) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: PathwayImported.
    Source: Reactome:R-HSA-2980785.

    This publication is mapped to 10 other entries.

  22. 22
    "Cytochrome P450 2S1 is reduced by NADPH-cytochrome P450 reductase."
    Xiao Y., Shinkyo R., Guengerich F.P.
    Drug Metab. Dispos. 39:944-946(2011) [PubMed] [Europe PMC] [Abstract]
    Annotation: P450 2S1 can be reduced by NADPH-P450 reductase and suggest normal mixed-function oxidase roles of P450 2S1 to be revealed.Imported.
    Source: GeneRIF:29785.

    This publication is mapped to 1 other entry.

  23. 23
    "Next-generation sequencing to generate interactome datasets."
    Yu H., Tardivo L., Tam S., Weiner E., Gebreab F., Fan C., Svrzikapa N., Hirozane-Kishikawa T., Rietman E., Yang X., Sahalie J., Salehi-Ashtiani K., Hao T., Cusick M.E., Hill D.E., Roth F.P., Braun P., Vidal M.
    Nat. Methods 8:478-480(2011) [PubMed] [Europe PMC] [Abstract]
    Category: Interaction.
    Source: IntAct:Q96SQ9.

    This publication is mapped to 793 other entries.

  24. 24
    "Characterization of a human keratinocyte HaCaT cell line model to study the regulation of CYP2S1."
    McNeilly A.D., Woods J.A., Ibbotson S.H., Wolf C.R., Smith G.
    Drug Metab. Dispos. 40:283-289(2012) [PubMed] [Europe PMC] [Abstract]
    Annotation: Data suggest that CYP2S1 is induced in a keratinocyte cell line by exposure to all-trans retinoic acid and ultraviolet B radiation.Imported.
    Source: GeneRIF:29785.

    This publication is mapped to 1 other entry.

  25. 25
    "[Polymorphic markers of the CYP1B1 (4326C > G), CYP2F1 (c.14_15insC), CYP2J2 (-76G > T), and CYP2S1 (13106C > T and 13255A > G) genes and genetic predisposition to chronic respiratory diseases induced by smoking and occupational factors]."
    Akhmadishina L.A., Korytina G.F., Victorova T.V.
    Genetika 47:1402-1410(2011) [PubMed] [Europe PMC] [Abstract]
    Annotation: No association has been found between the CYP2J2 (rs890293 -76G > T) or CYP2S1 (rs34971233 13106C > T P466L and rs338583 13255A > G) gene polymorphisms and respiratory diseases.Imported.
    Source: GeneRIF:29785.

    This publication is mapped to 32 other entries.

1 to 25 of 40  Show

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health